New Pain Drug Gets FDA Nod as Safer Alternative to Addictive Opioids
Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way ...
Pharmabiz1h
Lupin receives US FDA tentative approval for generic Symtuza tablets
Lupin receives US FDA tentative approval for generic Symtuza tablets: Our Bureau, Mumbai Monday, February 3, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The Thaiger6d
Major drug bust: 10,000 meth tablets found in fuel tank
A significant drug bust occurred when law enforcement intercepted a vehicle carrying 10,000 methamphetamine tablets hidden in ...
Orally Disintegrating Tablet Market Size, Growth & Forecats By 2033
The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...
dvm36011d
First generic drug for pruritus and cough conditions in dogs to be exhibited at VMX
Trimeprazine with Prednisolone Tablets, the generic equivalent of Temaril-P (Zoetis), will be displayed at this year’s ...
Future Market Insights4d
Global Aspirin Drug Market Set for Significant Growth, Projected to Reach USD 4,236.9 Million by 2034
The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...
ophthalmologytimes10d
FDA grants fast track designation to N-acetylcysteine amide tablets from Nacuity Pharmaceuticals
The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...